Ramistar 1.25 mg (ramipril) and Cardivas 3.125 mg (carvedilol) can both lower blood pressure, so monitoring BP after starting them is important. However, these medicines may have been prescribed for reasons other than BP control alone, such as cardiac protection or heart failure, so they should not be stopped or reduced without discussing it with the prescribing doctor.
Since your mother has COPD, it is also important to know why Cardivas was prescribed and whether she has any cardiac condition, as carvedilol is a beta-blocker and may not be suitable for every COPD patient.
Please monitor her BP and pulse regularly, particularly after taking the medicines. If she develops marked dizziness, fainting, unusual weakness, very low BP, slow pulse or worsening breathlessness/wheezing, she should be reviewed promptly.
If you share her recent BP readings, pulse rate, ECG/echo reports and the complete prescription, I can review them and explain whether the medicines and doses appear appropriate.
For a detailed review of her COPD treatment and prescription, you can also consult me directly on Practo through an online consultation.
Answered2026-10-08 18:15:33
Let others know if this answer was helpful